Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
urological drugs
MedTech
Boston Scientific to pick up Lumenis' surgical lasers for $1B
Boston Scientific aims to acquire Lumenis’ global surgical laser business, through a $1.07 billion deal.
Conor Hale
Mar 3, 2021 10:35am
As Urovant preps vibegron launch, it’s all systems go on R&D
Aug 14, 2020 8:13am
Astellas alum Robinson takes the helm at Urovant
Mar 24, 2020 10:30am
UroGen’s UGN-101 clears 57% of tumors in pivotal trial
Jan 8, 2019 10:55am
Ex-Novartis Oncology CEO Barrett joins UroGen
Jan 3, 2019 6:55am
Urovant starts pursuit of Astellas’ incontinence drug Myrbetriq
Mar 28, 2018 9:29am
